Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Project title: NHS National Framework for the supply of Ustekinumab 1 September 2024<br/><br/>Offer reference number: CM/TNS/24/5711<br/><br/>CM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & South of England. Period of framework: 1 September 2024 to 31 August 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.<br/><br/>CM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North of England and Midlands & East. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.<br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Accord-UK Ltd | 00079585 | ~£579,000,000 estimated from lot values | 2 lots CM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & South · CM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North & MAE | - |
| Amgen Ltd | 02354269 | ~£579,000,000 estimated from lot values | 2 lots CM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & South · CM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North & MAE | - |
| Celltrion Healthcare United Kingdom Limited | 11685363 | ~£579,000,000 estimated from lot values | 2 lots CM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & South · CM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North & MAE | - |
| Janssen-Cilag Ltd | 01027904 | ~£579,000,000 estimated from lot values | 2 lots CM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & South · CM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North & MAE | LOBBYIST Ovid Consulting Ltd (4 quarters) |
| Sandoz Ltd | 01547204 | ~£579,000,000 estimated from lot values | 2 lots CM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & South · CM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North & MAE | - |
| Thornton and Ross Ltd | 00185947 | ~£579,000,000 estimated from lot values | 2 lots CM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & South · CM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North & MAE | - |
This procurement was divided into 2 lots, each awarded separately. 72 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 CM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & South Sept 2024 – Aug 2026 | £300,000,000 £6 initial term | 6 | Amgen Ltd Sandoz Ltd Thornton and Ross Ltd Celltrion Healthcare United Kingdom Limited Janssen-Cilag Ltd Accord-UK Ltd | active |
| Lot 2 CM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North & MAE Sept 2024 – Aug 2025 | £279,000,000 £6 initial term | 6 | Amgen Ltd Sandoz Ltd Thornton and Ross Ltd Celltrion Healthcare United Kingdom Limited Janssen-Cilag Ltd Accord-UK Ltd | active |
Weightings from the notice, applied to every lot.
Government spending data: These suppliers have received £64,772,323 in 2,045 payments (over £25k) from Department of Health and Social Care, Guy's and St Thomas' NHS FT, East Sussex Healthcare NHS Trust, Worcestershire Acute Hospitals NHS Trust, United Lincolnshire Hospitals NHS Trust and 15 more public bodies (2010-08-03 to 2026-03-31).
Published by the buyer on this notice. Check the original notice — details change and are not updated here.